Venom Peptide: Definition

Detailed Explanation

Venom peptides are bioactive compounds produced by venomous animals — snakes, cone snails, scorpions, spiders, wasps, sea anemones, and the Gila monster — as part of their predatory or defensive arsenal. Venoms are complex cocktails containing dozens to hundreds of peptides, each evolved over millions of years to hit specific molecular targets (ion channels, receptors, enzymes) with extraordinary potency and selectivity. This makes venoms a treasure trove for drug discovery: nature has already done the high-throughput screening.

Several blockbuster drugs originated from venom peptides. Captopril (first ACE inhibitor, for hypertension) was developed from a bradykinin-potentiating peptide in Brazilian pit viper (Bothrops jararaca) venom. Exenatide (first GLP-1 drug, for diabetes) came from Gila monster (Heloderma suspectum) saliva. Ziconotide (Prialt, for severe chronic pain) is a synthetic version of ω-conotoxin MVIIA from the marine cone snail Conus magus. Eptifibatide (Integrilin, antiplatelet drug) was derived from pygmy rattlesnake venom.

Cone snail venoms alone contain an estimated 100,000+ unique peptides (conotoxins), most of which remain uncharacterized — representing an enormous untapped pharmacopeia. Modern 'venomics' combines proteomic analysis of venom composition with high-throughput functional screening to accelerate the identification of drug leads. Venom peptides are particularly promising for targets that small molecules struggle to address, such as ion channel subtypes and protein–protein interactions.

Key Facts

← Back to Full Dictionary

Part of the PeptideBond.com education network